IPA’s Jain Predicts 3-4 Weeks To Meet Indian Shortages
Current IGBA Chair Also Insists On Global Collaboration For Vaccine
Speaking exclusively to Generics Bulletin, Indian Pharmaceutical Alliance secretary general Sudarshan Jain says that India’s needs for COVID drugs like favipiravir, remdesivir and tocilizumab will be met “in the near future.” Current IGBA chair Jain also talks about global collaboration by governments and donors for equal vaccine distribution through the Access to COVID-19 Tools Accelerator.
